CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $26.14 | $131K | 49,290 |
| 2023-01-03 | Vazquez Martin Chief Operating Officer | Option exercise · Performance Options (right to buy) | −5,000 | 73,007 | ||
| 2023-01-03 | Trigg Leslie Chair and CEO | Option exercise | +30,000 | $3.88 | $116K | 320,243 |
| 2023-01-03 | Trigg Leslie Chair and CEO | Sale | −30,000 | $25.26 | $758K | 290,243 |
| 2023-01-03 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) | −30,000 | 70,508 | ||
| 2022-12-01 | Vazquez Martin Chief Operating Officer | Option exercise | +5,000 | $3.88 | $19K | 54,290 |
| 2022-12-01 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $20.85 | $104K | 49,290 |
| 2022-12-01 | Vazquez Martin Chief Operating Officer | Option exercise · Performance Options (right to buy) | −5,000 | 78,007 | ||
| 2022-12-01 | Trigg Leslie Chair and CEO | Option exercise | +8,717 | $3.88 | $34K | 298,960 |
| 2022-12-01 | Trigg Leslie Chair and CEO | Sale | −8,717 | $20.85 | $182K | 290,243 |
| 2022-12-01 | Trigg Leslie Chair and CEO | Option exercise | +21,283 | $3.88 | $83K | 311,526 |
| 2022-12-01 | Trigg Leslie Chair and CEO | Sale | −21,283 | $20.85 | $444K | 290,243 |
| 2022-12-01 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) | −8,717 | 121,791 | ||
| 2022-12-01 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) | −21,283 | 100,508 | ||
| 2022-11-30 | Brottem John L. General Counsel | Option exercise | +12,761 | $9.48 | $121K | 43,805 |
| 2022-11-30 | Brottem John L. General Counsel | Sale | −12,761 | $20.34 | $259K | 31,044 |
| 2022-11-30 | Brottem John L. General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) | −12,761 | 25,462 | ||
| 2022-11-22 | Hinrichs James F. Director | Purchase | +7,500 | $17.84 | $134K | 47,668 |
| 2022-11-18 | Brottem John L. General Counsel | Sale | −1,918 | $19.00 | $36K | 31,044 |
| 2022-11-16 | Brottem John L. General Counsel | Sale | −352 | $19.28 | $7K | 32,962 |
Page 17 of 18 · 343 trades